发明名称 Quinazoline compounds and pharmaceutical compositions containing them
摘要 <p>The use of a compound of formula (I) or a salt, ester or amide thereof; where X is O, or S, S(O) or S(O)<SUB>2</SUB>, NH or NR<SUP>8 </SUP>where R<SUP>8 </SUP>is hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>a </SUP>is a 3-quinoline group or a group of sub-formula (i) where R<SUP>5</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>are various specific organic groups, in the preparation of a medicament for use in the inhibtion of aurora 2 kinase. Novel compounds of formula (I) and pharmaceutical compositions useful in the treatment of cancer are also described and claimed.</p>
申请公布号 AU763242(B2) 申请公布日期 2003.07.17
申请号 AU20000074325 申请日期 2000.09.18
申请人 ASTRAZENECA AB 发明人 ANDREW AUSTEN MORTLOCK;NICHOLAS JOHN KEEN
分类号 C07D239/88;A61K;A61K31/517;A61K31/5377;A61P;A61P35/00;A61P43/00;C07D239/94;C07D401/12;C07D405/12;(IPC1-7):C07D239/94 主分类号 C07D239/88
代理机构 代理人
主权项
地址